Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick C Nucifora

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Psychiatry Research|April 5, 2026
Qualitative analysis of long-term clozapine adherence in schizophrenia: An exploratory studyDonald T G Daniel, Justin J Choi, James Aluri, et al.
Human Molecular Genetics|April 23, 2025
The nuclear export signal mediates mutant atrophin-1-induced neuropathology in a mouse model of DRPLAYideng Liang, Bo Ning, Xiaobo Wang, et al.
Science Advances|August 18, 2018
A mouse model of 22q11.2 deletions: Molecular and behavioral signatures of Parkinson's disease and schizophreniaAkiko Sumitomo, Kouta Horike, Kazuko Hirai, et al.
Molecular Neuropsychiatry|November 22, 2016
A Mutation in NPAS3 That Segregates with Schizophrenia in a Small Family Leads to Protein AggregationLeslie G Nucifora, YeeWen Candace Wu, Brian J Lee, et al.
Human Molecular Genetics|December 10, 2019
G2019S-LRRK2 mutation enhances MPTP-linked Parkinsonism in miceNicolas Arbez, XiaoFei He, Yong Huang, et al.
The Journal of Biological Chemistry|December 5, 2002
Nuclear localization of a non-caspase truncation product of atrophin-1, with an expanded polyglutamine repeat, increases cellular toxicityFrederick C Nucifora, Lisa M Ellerby, Cheryl L Wellington, et al.
Journal of Cellular Physiology|March 18, 2020
GTP-binding inhibitors increase LRRK2-linked ubiquitination and Lewy body-like inclusionsJoseph M Thomas, Xiaobo Wang, Gongbo Guo, et al.
Molecular Medicine Reports|March 18, 2016
Melatonin attenuates hLRRK2-induced sleep disturbances and synaptic dysfunction in a Drosophila model of Parkinson's diseaseXicui Sun, Dongzhi Ran, Xiaofeng Zhao, et al.
Molecular Psychiatry|February 2, 2023
Longitudinal changes in brain metabolites in healthy controls and patients with first episode psychosis: a 7-Tesla MRS studyMin Wang, Peter B Barker, Nicola G Cascella, et al.
Psychiatric Services (Washington, D.C.)|April 4, 2017
Risk of Hospitalization Due to Medication Nonadherence Identified Through EMRs of Patients With PsychosisCarrie E Andrews, Krista Baker, Carolyn J Howell, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Psychiatry Research|April 5, 2026
Qualitative analysis of long-term clozapine adherence in schizophrenia: An exploratory studyDonald T G Daniel, Justin J Choi, James Aluri, et al.
Human Molecular Genetics|April 23, 2025
The nuclear export signal mediates mutant atrophin-1-induced neuropathology in a mouse model of DRPLAYideng Liang, Bo Ning, Xiaobo Wang, et al.
Science Advances|August 18, 2018
A mouse model of 22q11.2 deletions: Molecular and behavioral signatures of Parkinson's disease and schizophreniaAkiko Sumitomo, Kouta Horike, Kazuko Hirai, et al.
Molecular Neuropsychiatry|November 22, 2016
A Mutation in NPAS3 That Segregates with Schizophrenia in a Small Family Leads to Protein AggregationLeslie G Nucifora, YeeWen Candace Wu, Brian J Lee, et al.
Human Molecular Genetics|December 10, 2019
G2019S-LRRK2 mutation enhances MPTP-linked Parkinsonism in miceNicolas Arbez, XiaoFei He, Yong Huang, et al.
The Journal of Biological Chemistry|December 5, 2002
Nuclear localization of a non-caspase truncation product of atrophin-1, with an expanded polyglutamine repeat, increases cellular toxicityFrederick C Nucifora, Lisa M Ellerby, Cheryl L Wellington, et al.
Journal of Cellular Physiology|March 18, 2020
GTP-binding inhibitors increase LRRK2-linked ubiquitination and Lewy body-like inclusionsJoseph M Thomas, Xiaobo Wang, Gongbo Guo, et al.
Molecular Medicine Reports|March 18, 2016
Melatonin attenuates hLRRK2-induced sleep disturbances and synaptic dysfunction in a Drosophila model of Parkinson's diseaseXicui Sun, Dongzhi Ran, Xiaofeng Zhao, et al.
Molecular Psychiatry|February 2, 2023
Longitudinal changes in brain metabolites in healthy controls and patients with first episode psychosis: a 7-Tesla MRS studyMin Wang, Peter B Barker, Nicola G Cascella, et al.
Psychiatric Services (Washington, D.C.)|April 4, 2017
Risk of Hospitalization Due to Medication Nonadherence Identified Through EMRs of Patients With PsychosisCarrie E Andrews, Krista Baker, Carolyn J Howell, et al.
Pageof 4